Locametz (gallium Ga 68 gozetotide) is a radioactive tracer that's used in positron emission tomography (PET) scans for males with certain types of prostate cancer. It helps your provider to determine whether cancer cells have spread from the prostate to other organs, or have come back after a period of time. Locametz (gallium Ga 68 gozetotide) is injected through the veins (intravenously, or IV) by a healthcare provider before your imaging study. It's available as two different brand-names, Locametz and Illuccix.
PET scans to find cancer cells in:
Men with treatable prostate cancer that might have spread to other organs
Men with a history of prostate cancer that has come back based on high levels of prostate-specific antigen (PSA)
Men with prostate cancer that might have spread to other organs that is treatable by Pluvicto (lutetium Lu 177 vipivotide tetraxetan) - Locametz only
PET scans to find cancer cells in:
Men with treatable prostate cancer that might have spread to other organs
Men with a history of prostate cancer that has come back based on high levels of prostate-specific antigen (PSA)
Men with prostate cancer that might have spread to other organs that is treatable by Pluvicto (lutetium Lu 177 vipivotide tetraxetan) - Locametz only
Men with treatable prostate cancer that might have spread to other organs
Men with a history of prostate cancer that has come back based on high levels of prostate-specific antigen (PSA)
By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men’s health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.